Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares were up 21.6% on Monday . The company traded as high as GBX 2.35 ($0.03) and last traded at GBX 2.34 ($0.03). Approximately 3,196,030 shares traded hands during mid-day trading, an increase of 143% from the average daily volume of 1,317,947 shares. The stock had previously closed at GBX 1.93 ($0.03).
Cizzle Biotechnology Trading Up 21.6 %
The stock’s fifty day moving average price is GBX 1.84 and its two-hundred day moving average price is GBX 1.79. The firm has a market capitalization of £9.28 million, a price-to-earnings ratio of -230.00 and a beta of 0.38.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- Compound Interest and Why It Matters When Investing
- Is Spotify Stock Poised to Soar? Options Traders Think So
- Options Trading – Understanding Strike Price
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Why Invest in High-Yield Dividend Stocks?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
